According to the Financial Times, Johnson & Johnson (JNJ.N) is seeking to acquire eye disease biotechnology company Ollin Biosciences for up to $3.4 billion.
2026-11-16
According to the Financial Times, Johnson & Johnson (JNJ.N) is seeking to acquire eye disease biotechnology company Ollin Biosciences for up to $3.4 billion.